Article Title |
Link |
|---|---|
| A Simple-to-Use Score for Identifying Individuals at High Risk of Denosumab-Associated Hypocalcemia in Postmenopausal Osteoporosis: A Real-World Cohort Study | https://link.springer.com/article/10.1007/s00223-020-00754-8 |
| Assessment of Cardiovascular Safety of Anti‑Osteoporosis Drugs | https://link.springer.com/article/10.1007%2Fs40265-020-01364-2 |
| Postmenopausal Osteoporosis – An Indian Perspective | https://www.cmijournal.org/article.asp?issn=0973-4651;year=2020;volume=18;issue=2;spage=98;epage=104;aulast=Rajan |
| Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status | https://link.springer.com/article/10.1007%2Fs00774-020-01119-9 |
| RANKL as a therapeutic target of rheumatoid arthritis | https://link.springer.com/article/10.1007%2Fs00774-020-01159-1 |
| A Review on the Role of Denosumab in Fracture Prevention | https://www.dovepress.com/a-review-on-the-role-of-denosumab-in-fracture-prevention-peer-reviewed-fulltext-article-DDDT |
| Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions | https://www.aging-us.com/article/104117/text |